Tracey A Martin1, Amit Goyal, Gareth Watkins, Wen G Jiang. 1. Metastasis & Angiogenesis Research Group, University Department of Surgery, Wales College of Medicine, Cardiff University, Cardiff CF14 4XN, UK. martinta1@cf.ac.uk
Abstract
BACKGROUND: Slug, Snail, and Twist are transcription factors that regulate the expression of tumor suppressors such as E-cadherin. We examined the distribution and expression of these three molecules together with the methylation of the Twist gene promoter in human breast cancer to elucidate their clinical significance. METHODS: Frozen sections from breast cancer primary tumors (tumor, n = 114; background, n = 30) were immunostained with Slug, Snail, and Twist antibodies. RNA was reverse-transcribed, quantified, and analyzed by quantitative polymerase chain reaction (Q-PCR). Results were expressed as copy number of transcript per 50 ng of RNA (standardized against beta-actin). RESULTS: Immunohistochemistry revealed that all three molecules were stained in mammary tissues, with an increase in Twist within tumor tissues; this was supported by Q-PCR analysis. Q-PCR analysis showed that Slug was elevated with increasing tumor grade and prognostic indices. Twist was elevated with increasing nodal involvement (tumor-node-metastasis status). Conversely, Snail was reduced in expression corresponding with prognostic indices and tumor grade. Increased levels of Slug were associated with tumors from patients with metastatic disease or disease recurrence, and increased expression of Twist was associated with tumors from patients who had died from breast cancer. It is interesting to note that Snail expression was significantly reduced in patients with a poor outcome and those who had node-positive tumors. In addition, tumors exhibited methylation of the Twist promoter. CONCLUSIONS: These data demonstrate that all three transcription factors have inappropriate expression in breast cancer and that this may play a part in the progression of human breast tumors.
BACKGROUND:Slug, Snail, and Twist are transcription factors that regulate the expression of tumor suppressors such as E-cadherin. We examined the distribution and expression of these three molecules together with the methylation of the Twist gene promoter in humanbreast cancer to elucidate their clinical significance. METHODS: Frozen sections from breast cancer primary tumors (tumor, n = 114; background, n = 30) were immunostained with Slug, Snail, and Twist antibodies. RNA was reverse-transcribed, quantified, and analyzed by quantitative polymerase chain reaction (Q-PCR). Results were expressed as copy number of transcript per 50 ng of RNA (standardized against beta-actin). RESULTS: Immunohistochemistry revealed that all three molecules were stained in mammary tissues, with an increase in Twist within tumor tissues; this was supported by Q-PCR analysis. Q-PCR analysis showed that Slug was elevated with increasing tumor grade and prognostic indices. Twist was elevated with increasing nodal involvement (tumor-node-metastasis status). Conversely, Snail was reduced in expression corresponding with prognostic indices and tumor grade. Increased levels of Slug were associated with tumors from patients with metastatic disease or disease recurrence, and increased expression of Twist was associated with tumors from patients who had died from breast cancer. It is interesting to note that Snail expression was significantly reduced in patients with a poor outcome and those who had node-positive tumors. In addition, tumors exhibited methylation of the Twist promoter. CONCLUSIONS: These data demonstrate that all three transcription factors have inappropriate expression in breast cancer and that this may play a part in the progression of humanbreast tumors.
Authors: Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai A Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson Journal: J Mammary Gland Biol Neoplasia Date: 2010-06-04 Impact factor: 2.673
Authors: A Stoyianni; G Pentheroudakis; H Benjamin; A Cervantes; K Ashkenazi; G Lazaridis; N Pavlidis; Y Spector Journal: Clin Transl Oncol Date: 2013-11-27 Impact factor: 3.405
Authors: Janine M Low-Marchelli; Veronica C Ardi; Edward A Vizcarra; Nico van Rooijen; James P Quigley; Jing Yang Journal: Cancer Res Date: 2013-01-15 Impact factor: 12.701
Authors: Claudia Palena; Mario Roselli; Mary T Litzinger; Patrizia Ferroni; Leopoldo Costarelli; Antonella Spila; Francesco Cavaliere; Bruce Huang; Romaine I Fernando; Duane H Hamilton; Caroline Jochems; Kwong-Yok Tsang; Qing Cheng; H Kim Lyerly; Jeffrey Schlom; Fiorella Guadagni Journal: J Natl Cancer Inst Date: 2014-05-09 Impact factor: 13.506